vs

Side-by-side financial comparison of HWH International Inc. (HWH) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.

60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $206.8K, roughly 1.5× HWH International Inc.). HWH International Inc. runs the higher net margin — -140.7% vs -474.2%, a 333.4% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -40.2%). HWH International Inc. produced more free cash flow last quarter ($-217.9K vs $-1.8M).

HWH International Inc operates in the global luxury hospitality and lifestyle services industry, providing premium travel membership programs, curated high-end travel experiences, and exclusive access to luxury resorts, fine dining venues, and premium leisure facilities. Its key markets include North America, Asia Pacific, and Europe, serving high-net-worth individuals and corporate clients.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

HWH vs SXTP — Head-to-Head

Bigger by revenue
SXTP
SXTP
1.5× larger
SXTP
$303.4K
$206.8K
HWH
Growing faster (revenue YoY)
SXTP
SXTP
+65.7% gap
SXTP
25.6%
-40.2%
HWH
Higher net margin
HWH
HWH
333.4% more per $
HWH
-140.7%
-474.2%
SXTP
More free cash flow
HWH
HWH
$1.6M more FCF
HWH
$-217.9K
$-1.8M
SXTP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
HWH
HWH
SXTP
SXTP
Revenue
$206.8K
$303.4K
Net Profit
$-291.0K
$-1.4M
Gross Margin
59.8%
60.2%
Operating Margin
-142.7%
-632.0%
Net Margin
-140.7%
-474.2%
Revenue YoY
-40.2%
25.6%
Net Profit YoY
46.9%
29.7%
EPS (diluted)
$-8.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HWH
HWH
SXTP
SXTP
Q4 25
$303.4K
Q3 25
$206.8K
$437.6K
Q2 25
$310.4K
$100.9K
Q1 25
$163.6K
Q4 24
$287.1K
$241.6K
Q3 24
$345.5K
$135.3K
Q2 24
$334.9K
$125.0K
Q1 24
$286.1K
$105.7K
Net Profit
HWH
HWH
SXTP
SXTP
Q4 25
$-1.4M
Q3 25
$-291.0K
$-2.3M
Q2 25
$83.4K
$-1.7M
Q1 25
$-1.9M
Q4 24
$-476.7K
$-2.0M
Q3 24
$-548.5K
$-2.2M
Q2 24
$-387.9K
$-4.2M
Q1 24
$-1.3M
$430.5K
Gross Margin
HWH
HWH
SXTP
SXTP
Q4 25
60.2%
Q3 25
59.8%
-22.9%
Q2 25
48.0%
50.4%
Q1 25
55.2%
Q4 24
39.6%
51.1%
Q3 24
46.3%
17.4%
Q2 24
49.2%
28.3%
Q1 24
57.1%
38.1%
Operating Margin
HWH
HWH
SXTP
SXTP
Q4 25
-632.0%
Q3 25
-142.7%
-531.4%
Q2 25
24.5%
-1590.0%
Q1 25
-1168.4%
Q4 24
-170.2%
-854.7%
Q3 24
-155.5%
-1566.0%
Q2 24
-120.5%
-3351.8%
Q1 24
-467.1%
-1270.4%
Net Margin
HWH
HWH
SXTP
SXTP
Q4 25
-474.2%
Q3 25
-140.7%
-529.3%
Q2 25
26.9%
-1717.7%
Q1 25
-1147.4%
Q4 24
-166.1%
-846.3%
Q3 24
-158.7%
-1596.4%
Q2 24
-115.8%
-3339.0%
Q1 24
-467.2%
407.4%
EPS (diluted)
HWH
HWH
SXTP
SXTP
Q4 25
$-8.26
Q3 25
$-0.66
Q2 25
$-1.25
Q1 25
$-1.56
Q4 24
$-51.96
Q3 24
$-2.92
Q2 24
$-21.12
Q1 24
$1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HWH
HWH
SXTP
SXTP
Cash + ST InvestmentsLiquidity on hand
$2.9M
$2.8M
Total DebtLower is stronger
$150.0K
Stockholders' EquityBook value
$2.8M
$3.5M
Total Assets
$5.2M
$5.4M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HWH
HWH
SXTP
SXTP
Q4 25
$2.8M
Q3 25
$2.9M
$4.1M
Q2 25
$3.7M
$2.0M
Q1 25
$3.5M
Q4 24
$4.4M
$3.4M
Q3 24
$836.3K
$5.0M
Q2 24
$958.9K
$1.6M
Q1 24
$1.1M
Total Debt
HWH
HWH
SXTP
SXTP
Q4 25
$150.0K
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
$150.0K
Q4 24
$150.0K
Q3 24
$150.0K
Q2 24
$150.0K
Q1 24
$150.0K
Stockholders' Equity
HWH
HWH
SXTP
SXTP
Q4 25
$3.5M
Q3 25
$2.8M
$4.4M
Q2 25
$3.2M
$2.4M
Q1 25
$4.1M
Q4 24
$2.8M
$4.0M
Q3 24
$-374.9K
$6.0M
Q2 24
$-3.6M
$3.0M
Q1 24
$-3.1M
$7.2M
Total Assets
HWH
HWH
SXTP
SXTP
Q4 25
$5.4M
Q3 25
$5.2M
$6.7M
Q2 25
$10.6M
$4.2M
Q1 25
$6.0M
Q4 24
$6.4M
$5.8M
Q3 24
$2.9M
$7.4M
Q2 24
$3.1M
$4.3M
Q1 24
$2.6M
$8.4M
Debt / Equity
HWH
HWH
SXTP
SXTP
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.06×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.02×
Q2 24
0.05×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HWH
HWH
SXTP
SXTP
Operating Cash FlowLast quarter
$-199.9K
$-1.7M
Free Cash FlowOCF − Capex
$-217.9K
$-1.8M
FCF MarginFCF / Revenue
-105.4%
-584.2%
Capex IntensityCapex / Revenue
8.7%
26.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HWH
HWH
SXTP
SXTP
Q4 25
$-1.7M
Q3 25
$-199.9K
$-2.1M
Q2 25
$26.9K
$-1.5M
Q1 25
$-1.6M
Q4 24
$-415.2K
$-1.6M
Q3 24
$-275.0K
$-1.7M
Q2 24
$-490.8K
$-1.2M
Q1 24
$-638.2K
$-1.1M
Free Cash Flow
HWH
HWH
SXTP
SXTP
Q4 25
$-1.8M
Q3 25
$-217.9K
$-2.1M
Q2 25
$-1.5M
Q1 25
$-1.6M
Q4 24
$-415.5K
Q3 24
$-277.1K
$-1.7M
Q2 24
$-516.8K
Q1 24
$-640.3K
FCF Margin
HWH
HWH
SXTP
SXTP
Q4 25
-584.2%
Q3 25
-105.4%
-484.2%
Q2 25
-1483.6%
Q1 25
-978.3%
Q4 24
-144.7%
Q3 24
-80.2%
-1252.8%
Q2 24
-154.3%
Q1 24
-223.8%
Capex Intensity
HWH
HWH
SXTP
SXTP
Q4 25
26.3%
Q3 25
8.7%
2.3%
Q2 25
46.9%
Q1 25
1.6%
Q4 24
0.1%
Q3 24
0.6%
10.2%
Q2 24
7.7%
Q1 24
0.7%
Cash Conversion
HWH
HWH
SXTP
SXTP
Q4 25
Q3 25
Q2 25
0.32×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons